Effect of use of Valeriana Officinalis On psychological symptoms and sleep disorders in patient with chronic schizophrenia

Effect of use of Valeriana Officinalis On psychological symptoms and sleep disorders in patient with chronic schizophrenia admitted in Sina hospital Jouneghan

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120709010222N18

Enrollment

Registered

2018-01-12

Start date

2018-01-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia. Schizophrenia

Interventions

Intervention 1: Intervention group:every night, One hour befor bedtime, receive one capsule of 350mg sedemin per oral. Intervention 2: Control group: receive 50 mg capsule containing starch as a place

Treatment - Drugs

Placebo

Intervention group:every night, One hour befor bedtime, receive one capsule of 350mg sedemin per oral.

Control group: receive 50 mg capsule containing starch as a placebo per oral.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic schizophrenia based on physician diagnosis and diagnostic criteria DSM V

Exclusion criteria

Exclusion criteria: The probable problems associated with the use of herbal medicines mentioned during the study Discharging or no possibility of participation in the study due to absence in the hospital

Design outcomes

Primary

Measure	Time frame
Psychological symptoms. Timepoint: Three weeks after intervention. Method of measurement: Anderson's Pittsburgh Questionnaires.;Sleep disorder. Timepoint: Three weeks after intervention. Method of measurement: Anderson's Pittsburgh Questionnaires.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoud Nikfarjam

Shahre-kord University of Medical Sciences

nikmas140@gmail.com+98 38 2746 3331

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026